Heart failure 99 - The Moxcon story

International Journal of Cardiology

Volumn 71, Issue 2, 1999, Pages 109-111

  Coats, Andrew J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEART FAILURE; HISTORY; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; IMIDAZOLES; SURVIVAL ANALYSIS;

EID: 0032862021     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00120-5     Document Type: Editorial

References (6)

1. Morris S.T., Reid J.L. Moxonidine: a review. J Hum Hypertens. 11:1997;629-635.
2. Esler M., Kaye D. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. J Auton Nerv Syst. 72:1998;210-219.
3. Rector T.S., Olivari M.T., Levine T.B., Francis G.S., Cohn I.N. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J. 114:1987;148-152.
4. Swan J.W., Anker S.D., Walton C., Godsland I.F., Clark A.L., Leyva F., et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 30:1997;527-532.
5. Zhang Y.H., Zhu J., Song Y.C. Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure. Int J Cardiol. 65:1998;233-238.
6. Tygesen H., Andersson B., Di Lenarda A., Rundqvist B., Sinagra G., Hjalmarson A., et al. Wennerblom: potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes. Int J Cardiol. 68:1999;171-177.